Yeshiva University Albert Einstein College of Medicine Family Advocacy Pediatric Emergency Medicine
Jacobi Medical Center Resident & Student Area
Lewis M. Fraad Department of Pediatrics (Resident Program)- Albert Einstein College of Medicine - Yeshiva University - Jacobi Medical Center - New York Lewis M. Fraad Department of Pediatrics (Resident Program)- Albert Einstein College of Medicine - Yeshiva University - Jacobi Medical Center - New York
Residency Program Faculty Research and Publications News and Events About the Department Contact Us
Faculty Profile

Back to Faculty listing

Michael G. Rosenberg, MD

Dr. Rosenberg is an Attending in the Division of Pediatric Infectious Diseases. He is committee member of the New York State HIV Clinical Guidelines Program. Dr. Rosenberg is board certified in Pediatric Infectious Diseases and he is an Associate Professor of Clinical Pediatrics at the Albert Einstein College of Medicine.

Undergraduate:
University of California at Berkeley
Graduate:
PhD in Microbiology, University of Iowa College of Medicine
Medical School:
University of Iowa College of Medicine
Training:
  • Internship and Residency: Montefiore Medical Center
  • Infectious Disease Fellowship: Montefiore Medical Center
Research and/or Clinical Interests:
  • Opportunistic infections
  • Cell mediated immunity in HIV
  • New treatments for HIV
Bibliography:
  • Lee AW, Sharp ER, O'Mahony A, Rosenberg MG, Iet al: Single-cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo human immunodeficiency virus type 1 infection. J Virol 2008;82:3702-12.
  • Ballan WM, Vu BA, Rosenberg MG, et al: Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity. J Immunol 2007;179:3362-70.
  • Abadi J, Sprecher E, Rosenberg MG, et al: Partial treatment interruption of protease inhibitor-based highly active antiretroviral therapy regimens in HIV-infected children. J Acquir Immune Defic Syndr 2006;41:298-303.
  • Jordan KA, Furlan SN, Rosenberg MG, et al: CD8 T cell effector maturation in HIV-1-infected children. Virology 2006;347:117-26.
  • Sharp ER, Barbour JD, Rosenberg MG, et al: Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1. J Infect Dis 2005;192:1772-80.
  • Legrand FA, Abadi J, Rosenberg MG, et al: Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients. AIDS 2005;19:1575-85.
  • Chandwani R, Jordan KA, Rosenberg MG, et al: Limited magnitude and breadth in the HLA-A2-restricted CD8 T-Cell response to Nef in children with vertically acquired HIV-1 infection. Scand J Immunol 2004;59:109-14.
  • Rosenberg M: HIV-related emregncies, in Crain EF, Gershel, JC (eds.): Clinical Manual of Emergency Pediatrics (4th ed), McGraw-Hill, New York, 2003, pp 354-60.
  • Sullivan PS, Beck DT, Rosenberg M, Dobroszycki J: Depression of blood cells in HIV-infected children and adolescents, in Shearer WT, Hanson IC (eds): Medical Management of AIDS in Children, Saunders/Elsevier, Philadelphia, 2003, pp 321-35.

Copyright © 2004 Lewis M. Fraad Department of Pediatrics. All rights reserved.

Lewis M. Fraad Department of Pediatrics
Albert Einstein College of Medicine at Yeshiva University
1400 Pelham Parkway South
Bronx, New York
10461

www.JacobiPeds.org